Wu and colleagues show that sialylation through ST3GAL1 promotes cell migration, invasion and TGF-β1-induced EMT, which results in paclitaxel resistance in ovarian cancer [88]. The gene discussed is ST3GAL1; the disease is ovarian carcinoma.